Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EQUATOR: Brexpiprazole maintenance in schizophrenia
NCT01668797Phase 3Completed
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization
- Start
- Oct 2012
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 3 trial of brexpiprazole in schizophrenia, sponsored by Otsuka Pharmaceutical Development & Commercialization. Started Oct 2012; status: completed.
02
Drugs
brexpiprazole
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT01668797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01668797.